Peter Fecci

Dr. Peter Fecci, a Professor of Neurosurgery at Duke University, specializes in brain tumor immunology and immunotherapy. He discusses groundbreaking strategies for activating T cells to target brain tumors, particularly focusing on glioblastoma. Insights into targeting MHC-I-negative tumor cells reveal promising avenues for treatment. The conversation also covers the complexities of brain cancer therapies and the immune dynamics affecting outcomes. With a balance of scientific rigor and personal anecdotes, the talk offers a hopeful look at advancements in brain tumor treatment.